GlassScriptPhysician profile
Kimberly E Cook
NPI 1124051099
$797.19
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $117 · 2023: $238 · 2024: $116 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.11 | 2021-2025 | |
| Novo Nordisk INC | $126.12 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $111.30 | 2021-2023 | Belsomra, Steglatro |
| Pfizer INC. | $86.61 | 2022-2025 | |
| Cequr Corporation | $76.37 | 2022-2024 | Cequr Simplicity |
| Mayne Pharma Commercial LLC | $33.34 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $32.45 | 2024 | Airsupra |
| Organon LLC | $26.17 | 2025 | Nexplanon |
| Glaxosmithkline, LLC. | $24.47 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.88 | 2021 | |
| Exact Sciences Corporation | $19.68 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $18.11 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.89 | 2021 | |
| Astellas Pharma US INC | $16.31 | 2023 | Veozah |
| Amgen INC. | $14.46 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.92 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.